- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
According to our latest study, the global Transforming Growth Factor Beta 1 market size was valued at USD 1500.4 million in 2022 and is forecast to a readjusted size of USD 3041.7 million by 2029 with a CAGR of 10.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
This report is a detailed and comprehensive analysis for global Transforming Growth Factor Beta 1 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Transforming Growth Factor Beta 1 market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Transforming Growth Factor Beta 1 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Transforming Growth Factor Beta 1 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Transforming Growth Factor Beta 1 market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transforming Growth Factor Beta 1
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transforming Growth Factor Beta 1 market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp and Isarna Therapeutics GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Transforming Growth Factor Beta 1 market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pirfenidone
Galunisertib
Others
Market segment by Application
IPF
Cancer
Others
Major players covered
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transforming Growth Factor Beta 1 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Transforming Growth Factor Beta 1, with price, sales, revenue and global market share of Transforming Growth Factor Beta 1 from 2018 to 2023.
Chapter 3, the Transforming Growth Factor Beta 1 competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transforming Growth Factor Beta 1 breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Transforming Growth Factor Beta 1 market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Transforming Growth Factor Beta 1.
Chapter 14 and 15, to describe Transforming Growth Factor Beta 1 sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Transforming Growth Factor Beta 1
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Transforming Growth Factor Beta 1 Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pirfenidone
1.3.3 Galunisertib
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Transforming Growth Factor Beta 1 Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 IPF
1.4.3 Cancer
1.4.4 Others
1.5 Global Transforming Growth Factor Beta 1 Market Size & Forecast
1.5.1 Global Transforming Growth Factor Beta 1 Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Transforming Growth Factor Beta 1 Sales Quantity (2018-2029)
1.5.3 Global Transforming Growth Factor Beta 1 Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Transforming Growth Factor Beta 1 Product and Services
2.1.4 Roche Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Shionogi Ltd
2.2.1 Shionogi Ltd Details
2.2.2 Shionogi Ltd Major Business
2.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Product and Services
2.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Shionogi Ltd Recent Developments/Updates
2.3 Acceleron Pharma Inc
2.3.1 Acceleron Pharma Inc Details
2.3.2 Acceleron Pharma Inc Major Business
2.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product and Services
2.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Acceleron Pharma Inc Recent Developments/Updates
2.4 Genzyme Corp
2.4.1 Genzyme Corp Details
2.4.2 Genzyme Corp Major Business
2.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Product and Services
2.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Genzyme Corp Recent Developments/Updates
2.5 Isarna Therapeutics GmbH
2.5.1 Isarna Therapeutics GmbH Details
2.5.2 Isarna Therapeutics GmbH Major Business
2.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product and Services
2.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Isarna Therapeutics GmbH Recent Developments/Updates
2.6 Scholar Rock
2.6.1 Scholar Rock Details
2.6.2 Scholar Rock Major Business
2.6.3 Scholar Rock Transforming Growth Factor Beta 1 Product and Services
2.6.4 Scholar Rock Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Scholar Rock Recent Developments/Updates
2.7 Sirnaomics Inc
2.7.1 Sirnaomics Inc Details
2.7.2 Sirnaomics Inc Major Business
2.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Product and Services
2.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sirnaomics Inc Recent Developments/Updates
2.8 Eli Lilly and Co
2.8.1 Eli Lilly and Co Details
2.8.2 Eli Lilly and Co Major Business
2.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Product and Services
2.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly and Co Recent Developments/Updates
2.9 Formation Biologics Inc
2.9.1 Formation Biologics Inc Details
2.9.2 Formation Biologics Inc Major Business
2.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Product and Services
2.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Formation Biologics Inc Recent Developments/Updates
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG Transforming Growth Factor Beta 1 Product and Services
2.10.4 Novartis AG Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novartis AG Recent Developments/Updates
3 Competitive Environment: Transforming Growth Factor Beta 1 by Manufacturer
3.1 Global Transforming Growth Factor Beta 1 Sales Quantity by Manufacturer (2018-2023)
3.2 Global Transforming Growth Factor Beta 1 Revenue by Manufacturer (2018-2023)
3.3 Global Transforming Growth Factor Beta 1 Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Transforming Growth Factor Beta 1 by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Transforming Growth Factor Beta 1 Manufacturer Market Share in 2022
3.4.2 Top 6 Transforming Growth Factor Beta 1 Manufacturer Market Share in 2022
3.5 Transforming Growth Factor Beta 1 Market: Overall Company Footprint Analysis
3.5.1 Transforming Growth Factor Beta 1 Market: Region Footprint
3.5.2 Transforming Growth Factor Beta 1 Market: Company Product Type Footprint
3.5.3 Transforming Growth Factor Beta 1 Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Transforming Growth Factor Beta 1 Market Size by Region
4.1.1 Global Transforming Growth Factor Beta 1 Sales Quantity by Region (2018-2029)
4.1.2 Global Transforming Growth Factor Beta 1 Consumption Value by Region (2018-2029)
4.1.3 Global Transforming Growth Factor Beta 1 Average Price by Region (2018-2029)
4.2 North America Transforming Growth Factor Beta 1 Consumption Value (2018-2029)
4.3 Europe Transforming Growth Factor Beta 1 Consumption Value (2018-2029)
4.4 Asia-Pacific Transforming Growth Factor Beta 1 Consumption Value (2018-2029)
4.5 South America Transforming Growth Factor Beta 1 Consumption Value (2018-2029)
4.6 Middle East and Africa Transforming Growth Factor Beta 1 Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2029)
5.2 Global Transforming Growth Factor Beta 1 Consumption Value by Type (2018-2029)
5.3 Global Transforming Growth Factor Beta 1 Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2029)
6.2 Global Transforming Growth Factor Beta 1 Consumption Value by Application (2018-2029)
6.3 Global Transforming Growth Factor Beta 1 Average Price by Application (2018-2029)
7 North America
7.1 North America Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2029)
7.2 North America Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2029)
7.3 North America Transforming Growth Factor Beta 1 Market Size by Country
7.3.1 North America Transforming Growth Factor Beta 1 Sales Quantity by Country (2018-2029)
7.3.2 North America Transforming Growth Factor Beta 1 Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2029)
8.2 Europe Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2029)
8.3 Europe Transforming Growth Factor Beta 1 Market Size by Country
8.3.1 Europe Transforming Growth Factor Beta 1 Sales Quantity by Country (2018-2029)
8.3.2 Europe Transforming Growth Factor Beta 1 Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Transforming Growth Factor Beta 1 Market Size by Region
9.3.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Transforming Growth Factor Beta 1 Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2029)
10.2 South America Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2029)
10.3 South America Transforming Growth Factor Beta 1 Market Size by Country
10.3.1 South America Transforming Growth Factor Beta 1 Sales Quantity by Country (2018-2029)
10.3.2 South America Transforming Growth Factor Beta 1 Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Transforming Growth Factor Beta 1 Market Size by Country
11.3.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Transforming Growth Factor Beta 1 Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Transforming Growth Factor Beta 1 Market Drivers
12.2 Transforming Growth Factor Beta 1 Market Restraints
12.3 Transforming Growth Factor Beta 1 Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Transforming Growth Factor Beta 1 and Key Manufacturers
13.2 Manufacturing Costs Percentage of Transforming Growth Factor Beta 1
13.3 Transforming Growth Factor Beta 1 Production Process
13.4 Transforming Growth Factor Beta 1 Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Transforming Growth Factor Beta 1 Typical Distributors
14.3 Transforming Growth Factor Beta 1 Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Transforming Growth Factor Beta 1 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Transforming Growth Factor Beta 1 Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Transforming Growth Factor Beta 1 Product and Services
Table 6. Roche Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Shionogi Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Shionogi Ltd Major Business
Table 10. Shionogi Ltd Transforming Growth Factor Beta 1 Product and Services
Table 11. Shionogi Ltd Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Shionogi Ltd Recent Developments/Updates
Table 13. Acceleron Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 14. Acceleron Pharma Inc Major Business
Table 15. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product and Services
Table 16. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Acceleron Pharma Inc Recent Developments/Updates
Table 18. Genzyme Corp Basic Information, Manufacturing Base and Competitors
Table 19. Genzyme Corp Major Business
Table 20. Genzyme Corp Transforming Growth Factor Beta 1 Product and Services
Table 21. Genzyme Corp Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Genzyme Corp Recent Developments/Updates
Table 23. Isarna Therapeutics GmbH Basic Information, Manufacturing Base and Competitors
Table 24. Isarna Therapeutics GmbH Major Business
Table 25. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product and Services
Table 26. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Isarna Therapeutics GmbH Recent Developments/Updates
Table 28. Scholar Rock Basic Information, Manufacturing Base and Competitors
Table 29. Scholar Rock Major Business
Table 30. Scholar Rock Transforming Growth Factor Beta 1 Product and Services
Table 31. Scholar Rock Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Scholar Rock Recent Developments/Updates
Table 33. Sirnaomics Inc Basic Information, Manufacturing Base and Competitors
Table 34. Sirnaomics Inc Major Business
Table 35. Sirnaomics Inc Transforming Growth Factor Beta 1 Product and Services
Table 36. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sirnaomics Inc Recent Developments/Updates
Table 38. Eli Lilly and Co Basic Information, Manufacturing Base and Competitors
Table 39. Eli Lilly and Co Major Business
Table 40. Eli Lilly and Co Transforming Growth Factor Beta 1 Product and Services
Table 41. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Eli Lilly and Co Recent Developments/Updates
Table 43. Formation Biologics Inc Basic Information, Manufacturing Base and Competitors
Table 44. Formation Biologics Inc Major Business
Table 45. Formation Biologics Inc Transforming Growth Factor Beta 1 Product and Services
Table 46. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Formation Biologics Inc Recent Developments/Updates
Table 48. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 49. Novartis AG Major Business
Table 50. Novartis AG Transforming Growth Factor Beta 1 Product and Services
Table 51. Novartis AG Transforming Growth Factor Beta 1 Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Novartis AG Recent Developments/Updates
Table 53. Global Transforming Growth Factor Beta 1 Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Transforming Growth Factor Beta 1 Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Transforming Growth Factor Beta 1 Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Transforming Growth Factor Beta 1, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Transforming Growth Factor Beta 1 Production Site of Key Manufacturer
Table 58. Transforming Growth Factor Beta 1 Market: Company Product Type Footprint
Table 59. Transforming Growth Factor Beta 1 Market: Company Product Application Footprint
Table 60. Transforming Growth Factor Beta 1 New Market Entrants and Barriers to Market Entry
Table 61. Transforming Growth Factor Beta 1 Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Transforming Growth Factor Beta 1 Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Transforming Growth Factor Beta 1 Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Transforming Growth Factor Beta 1 Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Transforming Growth Factor Beta 1 Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Transforming Growth Factor Beta 1 Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Transforming Growth Factor Beta 1 Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Transforming Growth Factor Beta 1 Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Transforming Growth Factor Beta 1 Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Transforming Growth Factor Beta 1 Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Transforming Growth Factor Beta 1 Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Transforming Growth Factor Beta 1 Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Transforming Growth Factor Beta 1 Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Transforming Growth Factor Beta 1 Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Transforming Growth Factor Beta 1 Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Transforming Growth Factor Beta 1 Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Transforming Growth Factor Beta 1 Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Transforming Growth Factor Beta 1 Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Transforming Growth Factor Beta 1 Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Transforming Growth Factor Beta 1 Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Transforming Growth Factor Beta 1 Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Transforming Growth Factor Beta 1 Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Transforming Growth Factor Beta 1 Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Transforming Growth Factor Beta 1 Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Transforming Growth Factor Beta 1 Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Transforming Growth Factor Beta 1 Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Transforming Growth Factor Beta 1 Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Transforming Growth Factor Beta 1 Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Transforming Growth Factor Beta 1 Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Transforming Growth Factor Beta 1 Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Transforming Growth Factor Beta 1 Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Transforming Growth Factor Beta 1 Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Transforming Growth Factor Beta 1 Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Transforming Growth Factor Beta 1 Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Transforming Growth Factor Beta 1 Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Transforming Growth Factor Beta 1 Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Transforming Growth Factor Beta 1 Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Transforming Growth Factor Beta 1 Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Transforming Growth Factor Beta 1 Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Transforming Growth Factor Beta 1 Raw Material
Table 121. Key Manufacturers of Transforming Growth Factor Beta 1 Raw Materials
Table 122. Transforming Growth Factor Beta 1 Typical Distributors
Table 123. Transforming Growth Factor Beta 1 Typical Customers
List of Figures
Figure 1. Transforming Growth Factor Beta 1 Picture
Figure 2. Global Transforming Growth Factor Beta 1 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Transforming Growth Factor Beta 1 Consumption Value Market Share by Type in 2022
Figure 4. Pirfenidone Examples
Figure 5. Galunisertib Examples
Figure 6. Others Examples
Figure 7. Global Transforming Growth Factor Beta 1 Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Transforming Growth Factor Beta 1 Consumption Value Market Share by Application in 2022
Figure 9. IPF Examples
Figure 10. Cancer Examples
Figure 11. Others Examples
Figure 12. Global Transforming Growth Factor Beta 1 Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Transforming Growth Factor Beta 1 Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Transforming Growth Factor Beta 1 Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Transforming Growth Factor Beta 1 Average Price (2018-2029) & (USD/Unit)
Figure 16. Global Transforming Growth Factor Beta 1 Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Transforming Growth Factor Beta 1 Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Transforming Growth Factor Beta 1 by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Transforming Growth Factor Beta 1 Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Transforming Growth Factor Beta 1 Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Transforming Growth Factor Beta 1 Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Transforming Growth Factor Beta 1 Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Transforming Growth Factor Beta 1 Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Transforming Growth Factor Beta 1 Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Transforming Growth Factor Beta 1 Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Transforming Growth Factor Beta 1 Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Transforming Growth Factor Beta 1 Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Transforming Growth Factor Beta 1 Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Transforming Growth Factor Beta 1 Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Transforming Growth Factor Beta 1 Average Price by Type (2018-2029) & (USD/Unit)
Figure 31. Global Transforming Growth Factor Beta 1 Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Transforming Growth Factor Beta 1 Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Transforming Growth Factor Beta 1 Average Price by Application (2018-2029) & (USD/Unit)
Figure 34. North America Transforming Growth Factor Beta 1 Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Transforming Growth Factor Beta 1 Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Transforming Growth Factor Beta 1 Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Transforming Growth Factor Beta 1 Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Transforming Growth Factor Beta 1 Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Transforming Growth Factor Beta 1 Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Transforming Growth Factor Beta 1 Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Transforming Growth Factor Beta 1 Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Transforming Growth Factor Beta 1 Consumption Value Market Share by Region (2018-2029)
Figure 54. China Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Transforming Growth Factor Beta 1 Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Transforming Growth Factor Beta 1 Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Transforming Growth Factor Beta 1 Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Transforming Growth Factor Beta 1 Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Transforming Growth Factor Beta 1 Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Transforming Growth Factor Beta 1 Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Transforming Growth Factor Beta 1 Market Drivers
Figure 75. Transforming Growth Factor Beta 1 Market Restraints
Figure 76. Transforming Growth Factor Beta 1 Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta 1 in 2022
Figure 79. Manufacturing Process Analysis of Transforming Growth Factor Beta 1
Figure 80. Transforming Growth Factor Beta 1 Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
